Search Results Search Sort by RelevanceMost Recent Case and Commentary Jan 2005 Futile Care: An Inoperable Cancer Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13-0501. Case and Commentary Nov 2012 Surgery for Placebo Effect? Commentary 1 C. Ronald MacKenzie, MD The Moseley study found no significant difference between those in the arthroscopic lavage and debridement arm of the study and those in the sham surgery arm. Virtual Mentor. 2012;14(11):825-828. doi: 10.1001/virtualmentor.2012.14.11.ecas1-1211. Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611. Case and Commentary Nov 2016 How Should Physicians Refer When Referral Options Are Limited for Transgender Patients? Elizabeth Dietz and Jessica Halem, MBA In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1070-1080. doi: 10.1001/journalofethics.2016.18.11.ecas1-1611. State of the Art and Science Nov 2016 What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care Madeline B. Deutsch, MD, MPH, Asa Radix, MD, MPH, and Sari Reisner, ScD Research should be conducted on transgender populations to inform evidence-based guidelines for gender-affirming treatment. AMA J Ethics. 2016;18(11):1098-1106. doi: 10.1001/journalofethics.2016.18.11.stas1-1611. Case and Commentary Nov 2012 Surgery for Placebo Effect? Commentary 2 Matthew J. Matava, MD and Charles Carroll IV, MD If a physician worries that a treatment will benefit the patient through the placebo effect, should he perform it? Virtual Mentor. 2012;14(11):828-834. doi: 10.1001/virtualmentor.2012.14.11.ecas1-1211. Case and Commentary Jan 2005 An Inoperable Cancer Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13a-0501. Case and Commentary Jan 2005 An Inoperable Cancer, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13b-0501. Case and Commentary Jan 2005 An Inoperable Cancer, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):68-73. doi: 10.1001/virtualmentor.2005.7.1.ccas13c-0501. Medicine and Society Nov 2019 How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes. AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980. Pagination First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Current page 4 Page 5 Page 6 Next page Next › Last page Last »
Case and Commentary Jan 2005 Futile Care: An Inoperable Cancer Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13-0501.
Case and Commentary Nov 2012 Surgery for Placebo Effect? Commentary 1 C. Ronald MacKenzie, MD The Moseley study found no significant difference between those in the arthroscopic lavage and debridement arm of the study and those in the sham surgery arm. Virtual Mentor. 2012;14(11):825-828. doi: 10.1001/virtualmentor.2012.14.11.ecas1-1211.
Policy Forum Nov 2016 Affirmative and Responsible Health Care for People with Nonconforming Gender Identities and Expressions Kristen L. Eckstrand, MD, PhD, Henry Ng, MD, MPH, and Jennifer Potter, MD Physicians should extend gender-affirming treatment to gender-nonconforming people, who experience discrimination and health disparities. AMA J Ethics. 2016;18(11):1107-1118. doi: 10.1001/journalofethics.2016.18.11.pfor1-1611.
Case and Commentary Nov 2016 How Should Physicians Refer When Referral Options Are Limited for Transgender Patients? Elizabeth Dietz and Jessica Halem, MBA In referring transgender patients for medical transition, clinicians should be guided by harm reduction, respect for autonomy, and continuity of care. AMA J Ethics. 2016;18(11):1070-1080. doi: 10.1001/journalofethics.2016.18.11.ecas1-1611.
State of the Art and Science Nov 2016 What’s in a Guideline? Developing Collaborative and Sound Research Designs that Substantiate Best Practice Recommendations for Transgender Health Care Madeline B. Deutsch, MD, MPH, Asa Radix, MD, MPH, and Sari Reisner, ScD Research should be conducted on transgender populations to inform evidence-based guidelines for gender-affirming treatment. AMA J Ethics. 2016;18(11):1098-1106. doi: 10.1001/journalofethics.2016.18.11.stas1-1611.
Case and Commentary Nov 2012 Surgery for Placebo Effect? Commentary 2 Matthew J. Matava, MD and Charles Carroll IV, MD If a physician worries that a treatment will benefit the patient through the placebo effect, should he perform it? Virtual Mentor. 2012;14(11):828-834. doi: 10.1001/virtualmentor.2012.14.11.ecas1-1211.
Case and Commentary Jan 2005 An Inoperable Cancer Option Assessment Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13a-0501.
Case and Commentary Jan 2005 An Inoperable Cancer, Option Comparison Faith Lagay, PhD Virtual Mentor. 2005;7(1):74-79. doi: 10.1001/virtualmentor.2005.7.1.ccas13b-0501.
Case and Commentary Jan 2005 An Inoperable Cancer, Additional Information Faith Lagay, PhD Virtual Mentor. 2005;7(1):68-73. doi: 10.1001/virtualmentor.2005.7.1.ccas13c-0501.
Medicine and Society Nov 2019 How to Integrate Lived Experience Into Quality-of-Life Assessment in Patients Considering Facial Transplantation Laura L. Kimberly, MSW, MBE, Allyson R. Alfonso, Elie P. Ramly, MD, Rami S. Kantar, MD, Arthur L. Caplan, PhD, and Eduardo D. Rodriguez, MD, DDS Facial transplantation must establish approaches to assessing QoL in candidates and recipients that use meaningful outcomes. AMA J Ethics. 2019;21(11):E980-987. doi: 10.1001/amajethics.2019.980.